A multidisciplinary panel of experts provides an overview of the economic burden of HIV and the role of pre-exposure prophylaxis (PrEP) in preventing HIV transmission. Ian Frank, MD and Jeffrey ...
HIV pre-exposure prophylaxis (PrEP) is a prevention strategy which includes the regular or event-driven use of antiretroviral medication to prevent HIV infection in adults. Several clinical trials ...
A brand new drug might be more effective at preventing HIV than current methods. Many people take daily oral antiretroviral medication—known as PrEP (pre-exposure prophylaxis)—to protect themselves ...
Real-world data show DoxyPEP implementation among PrEP users significantly reduces the incidence of chlamydia and syphilis.
ARLINGTON, Virginia, June 11-- The HIV Medicine Association issued the following statement by Chair W. David Hardy on the U.S. Preventive Services Task Force's final pre-exposure prophylaxis ...
Although adolescents and young adults comprise only one quarter of the sexually active population in the United States, ...
Pre-exposure prophylaxis (PrEP) is a medication regimen that is used to protect at-risk populations from HIV infection. The FDA approved the drug TRUVADA ...
Ryan Haumschild, PharmD, MS, MBA: Hello and welcome to this AJMC® Peer Exchange program titled, “From Evidence to Implementation: Clarifications Around the US Preventive Services Task Force ...
MONTRÉAL, March 25, 2025 /CNW/ - ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (GSK), with Pfizer Inc. (PFE) and Shionogi as shareholders, is pleased to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback